4934 Premier Anti-Aging Co.,Ltd. - Financial Results

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

4934

TSE Growth

Premier Anti-Aging Co.,Ltd.

662

JPY

(0.00%)

Mar 16, 10:09 am JST

4.15

USD

Mar 15, 9:09 pm EDT

Result

PTS

outside of trading hours

662.9

Mar 16, 10:13 am JST

Summary Chart Historical News Financial Result

Current Period Guidance

Annual

Result

Guidance History

Growth Rate

Profitability

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Jul, 2022	33,911	2,414	2,572	1,424	163.4	0	Sep 13, 2022	J-GAAP
Jul, 2023	26,400	-611	-631	-733	-84.2	0	Sep 14, 2023	J-GAAP
Jul, 2024	20,359	139	161	-1,483	-170.1	0	Sep 12, 2024	J-GAAP
Jul, 2025	16,160	617	599	471	54.1	0	Sep 11, 2025	J-GAAP
Jul, 2026 Guidance	16,500	300	300	300	34.4	0	Sep 11, 2025	J-GAAP
YoY	+2.1%	-51.4%	-49.9%	-36.3%	-36.4%

Revision Direction	Revision Date	Revenue	Operating Profit	Ordinary Profit	Net Profit	Revised Dividend	Accounting Standards
Jul, 2021	Oct 28, 2020	25,270	2,601	2,546	1,766	0*	J-GAAP
	Mar 15, 2021	31,500	4,400	4,380	2,710	0*	J-GAAP
Results	Sep 14, 2021	32,815	4,680	4,653	2,793	0*	J-GAAP
Jul, 2022	Sep 14, 2021	Available in future release
	Jun 13, 2022
Results	Sep 13, 2022
Jul, 2023	Sep 13, 2022
	Dec 14, 2022
	Jun 14, 2023
Results	Sep 14, 2023
Jul, 2024	Sep 14, 2023
	Mar 14, 2024
Results	Sep 12, 2024
Jul, 2025	Sep 12, 2024
	Jun 12, 2025
Results	Sep 11, 2025
Jul, 2026	Sep 11, 2025	16,500	300	300	300	0	J-GAAP

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Nov, 2014	673	－	Available in future release
Nov, 2015	842	+25.1
Nov, 2016	1,517	+80.2
Jul, 2017 Changed	2,328	－
Jul, 2018	4,975	+113.7
Jul, 2019	11,929	+139.8
Jul, 2020	20,508	+71.9
Jul, 2021	32,815	+60.0
Jul, 2022	33,911	+3.3
Jul, 2023	26,400	-22.1
Jul, 2024	20,359	-22.9
Jul, 2025	16,160	-20.6
Jul, 2026 Guidance	16,500	+2.1	300	-51.4	300	-49.9	34.4	-36.4

Fiscal Year	Revenue	Operating Profit	Operating Profit Margin	ROE	ROA	Total Asset Turnover Ratio	Adj. EPS
Jul, 2024	20,359	139	0.68	-21.60	-12.82	1.76	-170.1
Jul, 2025	16,160	617	3.82	7.40	4.46	1.53	54.1
Jul, 2026 Guidance	16,500	300	1.82	4.27	2.86	1.57	34.4

All-Time High

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	33,911	4,680	4,653	2,793	326.9
Fiscal Year	Jul, 2022	Jul, 2021	Jul, 2021	Jul, 2021	Jul, 2021

Second Half

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Feb - Jul, 2023	12,142	-720	-726	-707	-81.2	0	Sep 14, 2023	J-GAAP
Feb - Jul, 2024	9,710	344	360	202	23.2	0	Sep 12, 2024	J-GAAP
Feb - Jul, 2025	7,632	-360	-371	-110	-12.6	0	Sep 11, 2025	J-GAAP
Feb - Jul, 2026 Guidance	9,158	-326	-376	-145	-16.6	0	Mar 12, 2026	J-GAAP
YoY	+20.0%	+9.4%	-1.3%	-31.8%	-31.7%

Cash Flow

Annual

Fiscal Year	Operating Profit	Fee Cash Flow	Operating Cash Flow	Investing Cash Flow	Financial Cash Flow	Cash & Equivalents	Cash Ratio	Accounting Standards
Jul, 2023	-611	1,522	2,422	-900	179	4,659	38.39	J-GAAP
Jul, 2024	139	-115	425	-540	183	4,753	43.20	J-GAAP
Jul, 2025	617	1,243	1,472	-229	-1,337	4,655	45.91	J-GAAP

Actual Performance and Financial Trends

Accumulated Results 2nd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Aug - Jan, 2023	10,649	-205	-199	-1,685	-193.3	ー	Mar 14, 2024	J-GAAP
Aug - Jan, 2024	8,528	977	970	581	66.7	161.9	Mar 13, 2025	J-GAAP
Aug - Jan, 2025	7,342	626	676	445	51.1	225.3	Mar 12, 2026	J-GAAP
YoY	-13.9%	-35.9%	-30.3%	-23.4%	-23.4%

Quarterly Results

Result

Growth Rate

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Feb - Apr, 2024	4,790	208	243	235	27.0	4.3	Jun 13, 2024	J-GAAP
May - Jul, 2024	4,920	136	117	-33	-3.8	2.8	Sep 12, 2024	J-GAAP
Aug - Oct, 2024	4,230	622	625	414	47.5	14.7	Dec 13, 2024	J-GAAP
Nov - Jan, 2024	4,298	355	345	167	19.2	8.3	Mar 13, 2025	J-GAAP
Feb - Apr, 2025	3,972	289	244	181	20.8	7.3	Jun 12, 2025	J-GAAP
May - Jul, 2025	3,660	-649	-615	-291	-33.4	-17.7	Sep 11, 2025	J-GAAP
Aug - Oct, 2025	3,643	575	609	408	46.8	15.8	Dec 12, 2025	J-GAAP
Nov - Jan, 2025	3,699	51	67	37	4.3	1.4	Mar 12, 2026	J-GAAP
YoY	-13.9%	-85.6%	-80.6%	-77.8%	-77.8%

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Feb - Apr, 2021	8,456	－	Available in future release
May - Jul, 2021	9,049	+52.5
Aug - Oct, 2021	9,865	+36.8
Nov - Jan, 2021	8,105	+0.1
Feb - Apr, 2022	7,926	-6.3
May - Jul, 2022	8,015	-11.4
Aug - Oct, 2022	7,391	-25.1
Nov - Jan, 2022	6,867	-15.3
Feb - Apr, 2023	6,351	-19.9
May - Jul, 2023	5,791	-27.7
Aug - Oct, 2023	5,264	-28.8
Nov - Jan, 2023	5,385	-21.6
Feb - Apr, 2024	4,790	-24.6
May - Jul, 2024	4,920	-15.0
Aug - Oct, 2024	4,230	-19.6
Nov - Jan, 2024	4,298	-20.2
Feb - Apr, 2025	3,972	-17.1
May - Jul, 2025	3,660	-25.6
Aug - Oct, 2025	3,643	-13.9
Nov - Jan, 2025	3,699	-13.9	51	-85.6	67	-80.6	4.3	-77.6

All-Time High Quarterly Results

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	9,865	2,074	2,132	1,320	151.4
Fiscal Year	Oct, 2021	Oct, 2021	Oct, 2021	Oct, 2021	Oct, 2021

Key Balance Sheet Figures

Fiscal Year	BPS	Equity Ratio	Total Asset	Equity	Retained Earnings	Interest-Bearing Debt Ratio	Announce	Accounting Standards
Jul, 2023	872.60	62.7	12,135	7,609	4,888	0.30	Sep 14, 2023	J-GAAP
Jul, 2024	702.33	55.7	11,002	6,124	3,404	0.40	Sep 12, 2024	J-GAAP
Jul, 2025	756.65	65.1	10,140	6,598	3,876	0.17	Sep 11, 2025	J-GAAP
Aug - Jan, 2025	ー	67.0	10,488	7,027	4,322	0.19	Mar 12, 2026	J-GAAP

Premier Anti-Aging Co.,Ltd.(4934) Financial Results